Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT

Monopar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
45.82M 7.27M 8.19M 20.3M
Short-Term Investments
14.4M n/a 4.93M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
78.87K 66.43K 45.98K 217.75K
Total Current Assets
60.29M 7.33M 13.17M 20.52M
Property-Plant & Equipment
n/a 12.65K 61.23K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 12.65K 61.23K n/a
Total Assets
60.29M 7.35M 13.23M 20.52M
Account Payables
2.25M 1.76M 3.13M 1.58M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 48.58K n/a
Other Current Liabilities
n/a n/a -48.58K n/a
Total Current Liabilities
5.25M 1.76M 3.13M 1.58M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 8.41K n/a
Total Liabilities
5.25M 1.76M 3.14M 1.58M
Total Debt
n/a n/a 8.41K n/a
Common Stock
6.1K 14.9K 12.95K 12.6K
Retained Earnings
-75.79B -60.21M -51.8M -41.29M
Comprehensive Income
35.99K -14.13K 8.94K -3.16K
Shareholders Equity
55.04M 5.59M 10.09M 18.94M
Total Investments
14.4M n/a 4.93M n/a